{"database": "openregs", "table": "documents", "rows": [["FDA-1975-N-0336-0079", "FDA", "FDA-1975-N-0336", "Acknowledgment Letter from FDA CDER to Virtus Pharmaceuticals OPCO II, LLC ( Buchanan Ingersoll & Rooney, PC)", "Other", "Acknowledgement Letter/Receipt", "2017-09-05T04:00:00Z", 2017, 9, "2017-09-05T04:00:00Z", null, "2017-09-05T18:32:41Z", null, 0, 0, "0900006482b03f7f"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1975-N-0336-0079"], "units": {}, "query_ms": 0.6668749265372753, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}